IRRAS Announces Expansion of IRRAflow Launch to The Netherlands

Finalization of agreement with Dutch distribution partner allows access into another key European market

KM Innovations is a well-established partner with deep existing relationships in neurosurgical space

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced an exclusive distribution agreement with KM Innovations BV, a leading distributor of world-class neurosurgical medical devices and technologies in The Netherlands.

Recommended AI News: Storm ID And Zebra Medical Vision To Co-Develop Revolutionary New AI Based Osteoporosis Prevention Solution As Part Of UK-Israel Collaboration

“We are pleased to partner with KM Innovations to expand the commercial availability of our IRRAflow product line to physicians and patients throughout the Netherlands,” said Coenraad Tamse, Vice President of International Sales for IRRAS. “As we expand the launch of our products throughout Europe, this partnership strategically expands our commercial capabilities with a large and established distributor with 35 years of experience supplying cutting-edge neurosurgical technologies.”

Recommended AI News: TAAL Announces Agreement To Establish North American BitcoinSV Hosting Capacity To Support Large Scale Enterprise Clients

Sanne Krijnen, Managing Director of KM Innovations Medical, commented, “We are excited to add IRRAflowto our product portfolio as it allows us to bring our customers a next generation solution for the treatment of intracranial bleeding and hemorrhagic stroke.  This exclusive distribution agreement expands our proven record of success in bringing safe and effective, leading-edge medical technologies to our Dutch clients, and we look forward to our partnership with IRRAS.”

Recommended AI News: Morse Micro Announces An Additional $13 Million Funding Round To Accelerate Wi-Fi HaLow